AllianceBernstein
BEAM icon

AllianceBernstein’s Beam Therapeutics BEAM Stock Holding History

AllianceBernstein’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
127,630
+22,510
+21% +$680K ﹤0.01% 1811
2026
Q1 		$2.91M Buy
105,120
+4,400
+4% +$122K ﹤0.01% 1799
2025
Q4 		$2.79M Hold
100,720
– – ﹤0.01% 1822
2025
Q3 		$2.44M Buy
100,720
+1,300
+1% +$25.9K ﹤0.01% 1887
2025
Q2 		$1.69M Buy
99,420
+12,810
+15% +$223K ﹤0.01% 2028
2025
Q1 		$1.69M Sell
86,610
-126,194
-59% -$3.31M ﹤0.01% 1992
2024
Q4 		$5.28M Buy
212,804
+127,494
+149% +$3.25M ﹤0.01% 1464
2024
Q3 		$2.09M Sell
85,310
-2,800
-3% -$72.3K ﹤0.01% 1940
2024
Q2 		$2.06M Hold
88,110
– – ﹤0.01% 1932
2024
Q1 		$2.91M Buy
88,110
+3,880
+5% +$121K ﹤0.01% 1719
2023
Q4 		$2.29M Buy
84,230
+2,100
+3% +$52.2K ﹤0.01% 1865
2023
Q3 		$1.98M Sell
82,130
-7,400
-8% -$198K ﹤0.01% 1893
2023
Q2 		$2.86M Buy
89,530
+19,430
+28% +$631K ﹤0.01% 1707
2023
Q1 		$2.15M Hold
70,100
– – ﹤0.01% 1821
2022
Q4 		$2.74M Hold
70,100
– – ﹤0.01% 1728
2022
Q3 		$3.34M Buy
70,100
+300
+0.4% +$17.1K ﹤0.01% 1585
2022
Q2 		$2.7M Buy
69,800
+13,200
+23% +$525K ﹤0.01% 1763
2022
Q1 		$3.24M Buy
56,600
+200
+0.4% +$13.1K ﹤0.01% 1807
2021
Q4 		$4.5M Hold
56,400
– – ﹤0.01% 1681
2021
Q3 		$4.91M Buy
56,400
+2,000
+4% +$201K ﹤0.01% 1619
2021
Q2 		$7M Buy
54,400
+4,300
+9% +$343K ﹤0.01% 1420
2021
Q1 		$4.01M Hold
50,100
– – ﹤0.01% 1698
2020
Q4 		$4.09M Buy
50,100
+3,600
+8% +$177K ﹤0.01% 1606
2020
Q3 		$1.15M Buy
46,500
+17,800
+62% +$442K ﹤0.01% 2119
2020
Q2 		$804K Buy
28,700
+17,600
+159% +$379K ﹤0.01% 2310
2020
Q1 		$200K Buy
+11,100
New +$241K ﹤0.01% 2799

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

AllianceBernstein's BEAM Position: Q2 2026 in Review

AllianceBernstein increased its Beam Therapeutics (BEAM) stake by 21% in Q2 2026, buying an estimated $680K and bringing the position to 127,630 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1811.

AllianceBernstein first reported a position in BEAM in Q1 2020 and has held it in 26 quarters since. The position peaked at $7M in Q2 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • AllianceBernstein held 127,630 shares of Beam Therapeutics worth $3.04M as of Q2 2026.
  • AllianceBernstein bought 22,510 Beam Therapeutics shares in Q2 2026, an estimated $680K.
  • Beam Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1811 holding.
  • AllianceBernstein first reported a position in Beam Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • AllianceBernstein's Beam Therapeutics position peaked at $7M in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.